BACKGROUND: Nondaily smoking has increased among current U.S. smokers during the past decade and is practiced by a significant percentage of smokers. Although research in nondaily smoking has grown, little is known about levels of exposure to tobacco toxicants among nondaily smokers and their variation across ethnic groups. METHODS: We examined urinary levels of cotinine and a tobacco-specific nitrosamine (NNAL) in community participants. Associations between the biomarker data and smoking characteristics were evaluated with Spearman's correlation analysis. RESULTS: Participants included 28 Blacks, 4 Latinos, and 25 Whites who smoked at least 1 cigarette on 4-24 days in the past 30 days. Participants averaged 3.3 (SD = 2.1) cigarettes per day (cpd) on days smoked, they smoked an average of 13.0 (SD = 5.4) days in the past month, and they smoked nondaily for 10.5 (SD = 10.5) years. Median levels of creatinine-normalized cotinine and NNAL were 490.9 ng/mg and 140.7 pg/mg, respectively. NNAL and cotinine were highly correlated (r = .84); NNAL and cotinine were modestly correlated with cpd (r = .39 and r = .34; all p values <.05). The number of days smoked per month was not associated with any biomarker levels. CONCLUSIONS: Our findings demonstrate that nondaily smokers are, on average, exposed to significant levels of nicotine and carcinogenic nitrosamines, with exposures of 40%-50% of those seen in daily smokers. This level of exposure suggests a significant health risk. Nicotine and carcinogen exposure is most closely related to number of cigarettes smoked per day but not to number of days per month of smoking.
BACKGROUND: Nondaily smoking has increased among current U.S. smokers during the past decade and is practiced by a significant percentage of smokers. Although research in nondaily smoking has grown, little is known about levels of exposure to tobacco toxicants among nondaily smokers and their variation across ethnic groups. METHODS: We examined urinary levels of cotinine and a tobacco-specific nitrosamine (NNAL) in community participants. Associations between the biomarker data and smoking characteristics were evaluated with Spearman's correlation analysis. RESULTS:Participants included 28 Blacks, 4 Latinos, and 25 Whites who smoked at least 1 cigarette on 4-24 days in the past 30 days. Participants averaged 3.3 (SD = 2.1) cigarettes per day (cpd) on days smoked, they smoked an average of 13.0 (SD = 5.4) days in the past month, and they smoked nondaily for 10.5 (SD = 10.5) years. Median levels of creatinine-normalized cotinine and NNAL were 490.9 ng/mg and 140.7 pg/mg, respectively. NNAL and cotinine were highly correlated (r = .84); NNAL and cotinine were modestly correlated with cpd (r = .39 and r = .34; all p values <.05). The number of days smoked per month was not associated with any biomarker levels. CONCLUSIONS: Our findings demonstrate that nondaily smokers are, on average, exposed to significant levels of nicotine and carcinogenicnitrosamines, with exposures of 40%-50% of those seen in daily smokers. This level of exposure suggests a significant health risk. Nicotine and carcinogen exposure is most closely related to number of cigarettes smoked per day but not to number of days per month of smoking.
Authors: Maciej Lukasz Goniewicz; Mark D Eisner; Eduardo Lazcano-Ponce; Wioleta Zielinska-Danch; Bartosz Koszowski; Andrzej Sobczak; Christopher Havel; Peyton Jacob; Neal L Benowitz Journal: Nicotine Tob Res Date: 2011-01-21 Impact factor: 4.244
Authors: Maciej L Goniewicz; Christopher M Havel; Margaret Wilson Peng; Peyton Jacob; Delia Dempsey; Lisa Yu; Wioleta Zielinska-Danch; Bartosz Koszowski; Jan Czogala; Andrzej Sobczak; Neal L Benowitz Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-12 Impact factor: 4.254
Authors: Timothy B Baker; Megan E Piper; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Su-Young Kim; Suzanne Colby; David Conti; Gary A Giovino; Dorothy Hatsukami; Andrew Hyland; Suchitra Krishnan-Sarin; Raymond Niaura; Kenneth A Perkins; Benjamin A Toll Journal: Nicotine Tob Res Date: 2007-11 Impact factor: 4.244
Authors: Peyton Jacob; Christopher Havel; Do-Hoon Lee; Lisa Yu; Mark D Eisner; Neal L Benowitz Journal: Anal Chem Date: 2008-10-08 Impact factor: 6.986
Authors: Jian-Min Yuan; Woon-Puay Koh; Sharon E Murphy; Yunhua Fan; Renwei Wang; Steven G Carmella; Shaomei Han; Katie Wickham; Yu-Tang Gao; Mimi C Yu; Stephen S Hecht Journal: Cancer Res Date: 2009-03-24 Impact factor: 12.701
Authors: Kim Pulvers; Taneisha S Scheuermann; Ashley S Emami; Brittany Basora; Xianghua Luo; Samir S Khariwala; Jasjit S Ahluwalia Journal: Nicotine Tob Res Date: 2014-07-10 Impact factor: 4.244
Authors: Nicole L Nollen; Matthew S Mayo; Lauren Clark; Lisa Sanderson Cox; Samir S Khariwala; Kim Pulvers; Neal L Benowitz; Jasjit S Ahluwalia Journal: Drug Alcohol Depend Date: 2017-08-16 Impact factor: 4.492
Authors: Kim Pulvers; A Paula Cupertino; Taneisha S Scheuermann; Lisa Sanderson Cox; Yen-Yi Ho; Nicole L Nollen; Ruby Cuellar; Jasjit S Ahluwalia Journal: Ethn Dis Date: 2018-04-26 Impact factor: 1.847
Authors: Nicole L Nollen; Lisa Sanderson Cox; Matthew S Mayo; Edward F Ellerbeck; Sheshadri Madhusudhana; Jasjit S Ahluwalia Journal: Contemp Clin Trials Date: 2018-05-19 Impact factor: 2.226
Authors: Jenny E Ozga; Colleen Bays; Ilana Haliwa; Nicholas J Felicione; Stuart G Ferguson; Geri Dino; Melissa D Blank Journal: Exp Clin Psychopharmacol Date: 2021-02-25 Impact factor: 3.492
Authors: Edward F Ellerbeck; Nicole Nollen; Tresza D Hutcheson; Milind Phadnis; Sharon A Fitzgerald; James Vacek; Matthew R Sharpe; Gary A Salzman; Kimber P Richter Journal: JAMA Netw Open Date: 2018-09-07
Authors: Shrila Mazumder; Winnie Shia; Patrick B Bendik; Honest Achilihu; Connie S Sosnoff; Joseph R Alexander; Zuzheng Luo; Wanzhe Zhu; Brittany N Pine; June Feng; Benjamin C Blount; Lanqing Wang Journal: Int J Environ Res Public Health Date: 2022-03-19 Impact factor: 3.390